Pasello G - Search Results

1

Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need.

Pretelli G, Spagnolo CC, Ciappina G, Santarpia M, Pasello G. Pretelli G, et al. Among authors: pasello g. Int J Mol Sci. 2023 May 17;24(10):8878. doi: 10.3390/ijms24108878. Int J Mol Sci. 2023. PMID: 37240224 Free PMC article. Review.

2

Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).

Pasello G, Marulli G, Polo V, Breda C, Bonanno L, Loreggian L, Rea F, Favaretto A. Pasello G, et al. Anticancer Res. 2012 Dec;32(12):5393-9. Anticancer Res. 2012. PMID: 23225442

3

Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis.

Sidi R, Pasello G, Opitz I, Soltermann A, Tutic M, Rehrauer H, Weder W, Stahel RA, Felley-Bosco E. Sidi R, et al. Among authors: pasello g. Eur J Cancer. 2011 Jan;47(2):326-32. doi: 10.1016/j.ejca.2010.09.044. Epub 2010 Oct 29. Eur J Cancer. 2011. PMID: 21036600

4

Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma.

Mencoboni M, Filiberti RA, Taveggia P, Grosso F, Pasello G, Del Corso L, Muzio A, Polo V, Zucali P, Ceresoli GL, Soto Parra HJ, Auriati L, Simonassi C. Mencoboni M, et al. Among authors: pasello g. Oncol Res Treat. 2017;40(6):364-369. doi: 10.1159/000464410. Epub 2017 May 9. Oncol Res Treat. 2017. PMID: 28472807 Review.

5

Second and third line treatment in non-small cell lung cancer.

Favaretto A, Pasello G, Magro C, Schettino C, Gridelli C. Favaretto A, et al. Among authors: pasello g. Crit Rev Oncol Hematol. 2009 Aug;71(2):117-26. doi: 10.1016/j.critrevonc.2009.01.009. Epub 2009 Feb 26. Crit Rev Oncol Hematol. 2009. PMID: 19249227 Review.

6

Second and third line treatment in advanced non-small cell lung cancer.

Favaretto AG, Pasello G, Magro C. Favaretto AG, et al. Among authors: pasello g. Discov Med. 2009 Dec;8(43):204-9. Discov Med. 2009. PMID: 20040271 Free article.

7

Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma.

Bonanno L, Schiavon M, Nardo G, Bertorelle R, Bonaldi L, Galligioni A, Indraccolo S, Pasello G, Rea F, Favaretto A. Bonanno L, et al. Among authors: pasello g. Anticancer Res. 2010 Dec;30(12):5121-8. Anticancer Res. 2010. PMID: 21187500

8

Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.

Marulli G, Verderi E, Zuin A, Schiavon M, Battistella L, Perissinotto E, Romanello P, Favaretto AG, Pasello G, Rea F. Marulli G, et al. Among authors: pasello g. Interact Cardiovasc Thorac Surg. 2014 Aug;19(2):256-62; discussion 262. doi: 10.1093/icvts/ivu141. Epub 2014 May 13. Interact Cardiovasc Thorac Surg. 2014. PMID: 24824495

9

Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature.

Polo V, Zago G, Frega S, Canova F, Bonanno L, Favaretto A, Bonaldi L, Bertorelle R, Conte P, Pasello G. Polo V, et al. Among authors: pasello g. Am J Case Rep. 2015 Nov 3;16:782-9. doi: 10.12659/ajcr.894426. Am J Case Rep. 2015. PMID: 26525068 Free PMC article. Review.

10

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization.

Polo V, Pasello G, Frega S, Favaretto A, Koussis H, Conte P, Bonanno L. Polo V, et al. Among authors: pasello g. Oncotarget. 2016 May 3;7(18):25050-63. doi: 10.18632/oncotarget.7732. Oncotarget. 2016. PMID: 26933818 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page